Basic information Safety Supplier Related

Seribantumab

Basic information Safety Supplier Related

Seribantumab Basic information

Product Name:
Seribantumab
Synonyms:
  • Seribantumab
  • Research Grade Seribantumab(DHD48405)
  • Seribantumab (anti-ERBB3)
  • Research Grade Seribantumab
CAS:
1334296-12-6
MW:
0
Mol File:
Mol File
More
Less

Seribantumab Chemical Properties

form 
Liquid
color 
Colorless to light yellow
More
Less

Seribantumab Usage And Synthesis

Uses

Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models[1].

in vivo

Seribantumab (0.6-1 mg; i.p. twice weekly for once) reduces tumor growth in non-small cell lung cancer (NSCLC) patient-derived xenograft (PDX) mice model with a higher efficacy than afatinib, blocks phosphorylation of growth modulators and induces expression of apoptosis markers in vivo[1]. Seribantumab (1-10 mg; i.p. twice weekly for once) eliminates the vast majority of tumor cells and causes no significant change in overall animal health or weight in High-grade serous ovarian cancer (HGSOC) mice model[1].

Animal Model:Immunocompromised mice with LUAD-0061AS3 PDX tumors implanted[1]
Dosage:0.6, 0.75 and 1 mg
Administration:Intraperitoneal injection; 0.6, 0.75 and 1 mg for once
Result:Effectively reduced tumor growth of mice and time- and dose-dependently reduced phosphorylation of HER2, HER3, AKT, and ERK1/2. Induced the expression if proapoptotic protein, BIM.

References

[1] Odintsov I, et al. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions. Clin Cancer Res. 2021 Jun 1;27(11):3154-3166. DOI:10.1158/1078-0432.CCR-20-3605

SeribantumabSupplier

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Email
422450190@qq.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com